Ghazal Ghajari - Ph.D, Biotechnology, Department of Biotechnology, College of Science, University of Tehran.
Yasaman Bermas - Ph.D, Biotechnology, Department of Biotechnology, College of Science, University of Tehran
Mahnaz Saremi - Reference Health Laboratory, Ministry of Health and Medical Education.

Precision medicine is a medical approach that involves customizing therapy for an individual by using extensive biological and external data. The rapid progress in the disciplines of molecular biology, gene sequencing, machine learning, and related technologies has facilitated the use of precision medicine. This approach utilizes the wealth of comprehensive information obtained from these advancements to improve the decision-making process in clinical treatment for individuals, particularly in real-time scenarios during the progression of a disease. Diabetes mellitus is a significant worldwide health issue, requiring the implementation of novel strategies to enhance patient outcomes. The efficacy of conventional treatment options that use a uniform approach has been shown to be limited in effectively addressing the heterogeneous character of the illness. In recent times, personalized medicine has surfaced as a revolutionary resolution, customizing treatment strategies in accordance with an individual's health attributes, lifestyle choices, and genetic composition. This review underscores the significance of genetic screening in forecasting susceptibility to diabetes and treatment response, while also emphasizing the potential of pharmacogenomics to optimize medication selection.

Diabetes Mellitus, genes, Pharmacogenetics, Personalized Medicine